Inflammatory bowel disease (IBD), a chronic gut immune dysregulation and dysbiosis
condition is rapidly increasing in global incidence. Regardless, there is a lack of ideal …

Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease of unknown etiology,
involving complex interactions between the gut microbiome and host immune response. The …

Inflammatory bowel disease (IBD) is a relapsing chronic disorder of the gastrointestinal tract
characterized by disruption of epithelial barrier function and excessive immune response to …

Inflammatory Bowel Disease (IBD) is a multifactorial disorder that conceptually occurs as a
result of altered immune responses to commensal and/or pathogenic gut microbes in …

Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis
(UC), is a set of clinically chronic, relapsing gastrointestinal inflammatory disease and lacks …

Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD)
attributed to a dysregulated immune response towards intestinal microbiota. Although …

The perturbations of the gut microbiota and metabolites are closely associated with the
progression of inflammatory bowel disease (IBD). However, inconsistent findings across …

Introduction Biomarkers are needed in inflammatory bowel disease (IBD) to help define
disease activity and identify underlying pathogenic mechanisms. We hypothesized that …

Inflammatory bowel disease (IBD) is a chronic, complex relapsing disorder characterised by
immune dysregulation, gut microbiota alteration, and disturbed intestinal permeability. The …

Inflammatory bowel disease (IBD) is a chronic inflammatory disease. The disease has a
multifactorial aetiology, involving genetic, microbial as well as environmental factors. The …